Determinants of complications and adequacy of surgical resection in laparoscopic versus open total gastrectomy for adenocarcinoma.
BACKGROUND
The role of laparoscopic total gastrectomy (LTG) in the treatment of gastric cancer is controversial. The present study analyzed the morbidity and adequacy of resection in LTG versus open total gastrectomy (OTG) for gastric adenocarcinoma.


METHODS
Between 2003 and 2006, clinical data of 38 consecutive patients who underwent LTG for gastric adenocarcinoma were collected prospectively. The same data-entry form was used for retrospective data collection from 22 consecutive patients who underwent OTG within the same time period. Logistic regression models were used in univariate and multivariate analyses to identify the optimally combined factors related to the occurrence of postoperative complications and to the number of harvested lymph nodes.


RESULTS
Postoperative complications occurred in 24 patients with subsequent mortality in two. Median (range) length of hospital stay was 11 (6-73) days and comparable after LTG versus OTG (p = 0.847). The occurrence of postoperative complications was related (p = 0.004) to the first year of surgery and patients' medical condition before surgery [American Society of Anaesthesiologists (ASA) physical status III]. Microscopic tumor-free margins were obtained in all but two patients. The number of harvested lymph nodes was 17 (0-90), and determined by tumor wall penetration (p = 0.001).


CONCLUSIONS
The occurrence of complications after total gastrectomy is determined by the patients' medical condition before surgery and the surgical expertise, but not by the approach. LTG and OTG can result in adequate tumor-free resection margins and lymph node yield, which is related to the tumor wall penetration. The role of LTG in gastric cancer needs further evaluation in randomized controlled trials with large patient series.
Topal
B
B
Department of Abdominal Surgery, University Hospital Leuven, Herestraat 49, 3000, Leuven, Belgium. baki.topal@med.kuleuven.be
Leys
E
E
Ectors
N
N
Aerts
R
R
Penninckx
F
F
D000230:Adenocarcinoma / Q000601:surgery*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016009:Chi-Square Distribution; D005260:Female; D005743:Gastrectomy / Q000379:methods*; D006801:Humans; D010535:Laparoscopy / Q000379:methods*; D016015:Logistic Models; D008197:Lymph Node Excision; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011446:Prospective Studies; D018709:Statistics, Nonparametric; D013274:Stomach Neoplasms / Q000601:surgery*; D016896:Treatment Outcome
N Engl J Med. 1999 Mar 25;340(12):908-14
10089184
Ann Surg. 2003 Dec;238(6):777-81
14631214
Am J Surg. 2006 Dec;192(6):837-42
17161104
Surg Endosc. 2005 Jul;19(7):933-8
15920691
J Clin Oncol. 1998 Apr;16(4):1490-3
9552056
Ann Surg. 2007 Jan;245(1):68-72
17197967
Ann Surg. 1999 Jan;229(1):49-54
9923799
World J Surg. 2002 Sep;26(9):1145-9
12209244
Eur J Surg Oncol. 2005 May;31(4):401-5
15837047
Best Pract Res Clin Gastroenterol. 2006;20(4):767-87
16997159
Ann Surg. 1996 Jul;224(1):37-42
8678615
Ann Surg. 2004 Aug;240(2):205-13
15273542
Surg Laparosc Endosc Percutan Tech. 2005 Dec;15(6):309-14
16340559
N Engl J Med. 2001 Sep 6;345(10):725-30
11547741
Br J Surg. 2005 Jan;92(1):5-13
15635680
Ann Surg. 2005 Feb;241(2):232-7
15650632
N Engl J Med. 1979 Dec 20;301(25):1364-9
503167
Surg Endosc. 2007 Jan;21(1):21-7
17031743
Eur J Surg Oncol. 2005 Aug;31(6):595-604
15919174
N Engl J Med. 2006 Jul 6;355(1):11-20
16822992
Surg Endosc. 2007 Jan;21(1):28-33
16960676